{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:49:36Z","timestamp":1789778976888,"version":"4.0.1"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,23]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Type 2 diabetes mellitus is a major global health concern. Liraglutide, a glucagon-like peptide-1 receptor agonist, is widely used for glycemic control and weight loss. While generally safe, its misuse, particularly overdose, poses severe risks that are poorly documented. This case report aims to describe the clinical course and management of a life-threatening diabetic ketoacidosis (DKA) induced by a massive liraglutide overdose, highlighting the critical importance of patient education and adherence to prescribing guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We present a case report of a 43-year-old female with type 2 diabetes mellitus who self-administered liraglutide at 10 times the recommended dose (cumulative 18\u2009mg over 3 days).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Following the overdose, the patient was diagnosed with severe DKA (pH 6.9), with markedly elevated \u03b2-hydroxybutyrate and hyperkalemia. Conventional management failed to correct the life-threatening acidosis, necessitating salvage hemodialysis, which rapidly stabilized her metabolic parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This case underscores the dangers of liraglutide overdose, particularly for weight loss purposes, and highlights the critical need for strict adherence to prescribed dosages and comprehensive patient education. Clinicians should vigilantly monitor liraglutide therapy to prevent severe complications like DKA. In refractory DKA with profound acidosis (pH\u2005\u2264\u20057.0) or end-organ compromise, hemodialysis may be considered for rapid detoxification and stabilization. This report serves as a critical reminder of the potential dangers associated with glucagon-like peptide-1 receptor agonist misuse.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000046197","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T18:00:49Z","timestamp":1769191249000},"page":"e46197","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Diabetic ketoacidosis induced by liraglutide overdose for weight loss in a type 2 diabetes patient: A case report"],"prefix":"10.1097","volume":"105","author":[{"given":"Hekai","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Center of Coronary Circulation, Xiangya Hospital of Central South University, Changsha, China"},{"name":"Department of Geriatric Medicine, Center of Coronary Circulation, Xiangya Hospital of Central South University, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5897-353X","authenticated-orcid":false,"given":"Yuqin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Xiangya Hospital of Central South University, Changsha, China"},{"name":"State Key Laboratory of Advanced Medical Materials and Devices, Tianjin Key Laboratory of Biomedical Materials, Key Laboratory of Biomaterials and Nanotechnology for Cancer Immunotherapy, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, PR China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260610","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s40262-015-0343-6","article-title":"Liraglutide in type 2 diabetes mellitus: clinical pharmacokinetics and pharmacodynamics.","volume":"55","author":"Jacobsen","year":"2016","journal-title":"Clin Pharmacokinet"},{"key":"R2-20260610","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(09)60659-0","article-title":"Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).","volume":"374","author":"Buse","year":"2009","journal-title":"Lancet"},{"key":"R3-20260610","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1463-1326.2011.01523.x","article-title":"The role of GLP-1 mimetics and basal insulin analogues in type 2 diabetes mellitus: guidance from studies of liraglutide.","volume":"14","author":"Barnett","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"R4-20260610","doi-asserted-by":"crossref","first-page":"e39799","DOI":"10.1097\/MD.0000000000039799","article-title":"GLP-1 receptor agonist-induced diabetic ketoacidosis: a case report.","volume":"103","author":"Zhang","year":"2024","journal-title":"Medicine (Baltim)"},{"key":"R5-20260610","doi-asserted-by":"crossref","first-page":"e34027","DOI":"10.1097\/MD.0000000000034027","article-title":"Euglycemic diabetic ketoacidosis after the initiation of dulaglutide in patient with type 2 diabetes.","volume":"102","author":"Alduraibi","year":"2023","journal-title":"Medicine (Baltim)"},{"key":"R6-20260610","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00210-024-03384-1","article-title":"GLP-1 mimetics and diabetic ketoacidosis: possible interactions and clinical consequences.","volume":"398","author":"Forouzanmehr","year":"2025","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"R7-20260610","first-page":"e922753","article-title":"Comparison of combined hemodialysis and hemoperfusion with hemoperfusion alone in 106 patients with diabetic ketoacidosis and acute renal failure: a retrospective study from a single center in China.","volume":"27","author":"Wang","year":"2021","journal-title":"Med Sci Monit"},{"key":"R8-20260610","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00540-005-0385-2","article-title":"The use of continuous hemodiafiltration in a patient with diabetic ketoacidosis.","volume":"20","author":"Kawata","year":"2006","journal-title":"J Anesth"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046197","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T10:01:26Z","timestamp":1781085686000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046197","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"2025-02-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}